Clorox Co Überblick
Branche: Household & Personal Products
Sektor: Consumer Defensive
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States. The Household segment provides cat litter products under the Fresh Step and Scoop Away brands; bags and wraps under the Glad brand; and grilling products under the Kingsford brand in the United States. The Lifestyle segment offers dressings, dips, seasonings, and sauces primarily under the Hidden Valley brand; natural personal care products under the Burt's Bees brand; and water-filtration products under the Brita brand in the United States. The International segment provides laundry additives; home care products; water-filtration systems; digestive health products; grilling products; cat litter products; food products; bags and wraps; natural personal care products; and professional cleaning and disinfecting products internationally primarily under the Clorox, Ayudin, Clorinda, Poett, Pine-Sol, Glad, Brita, RenewLife, Ever Clean and Burt's Bees brands. The Clorox Company sells its products primarily through mass retailers; grocery outlets; warehouse clubs; dollar stores; home hardware centers; drug, pet and military stores; third-party and owned e-commerce channels; and distributors, as well as a direct sales force The company was founded in 1913 and is headquartered in Oakland, California. The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primar
Research-Überblick
Letztes Berichtsdatum 2026-08-03Diese Mavefund-Research-Seite bündelt geprüfte Informationen zu Clorox Co (CLX): Unternehmensprofil, Kursverlauf, verknüpfte Primärquellen, verfügbare Finanzberichte, Research-Signale und zu prüfende Risiken.
- Börsennotierung
- CLX · NYSE · MIC XNYS
- Land
- United States
- Handelswährung
- USD
- Branche
- Household & Personal Products
- Finanzdaten
- Jahres- und Zwischenabschlüsse verfügbar
- Letzte Primärquelle
- SEC EDGAR · veröffentlicht 2026-08-03
- Letzter Bericht · SEC EDGAR Veröffentlicht 2026-08-03
- Registrierungsdokument
Die Abdeckung wird automatisch aktualisiert und erst nach einer Datenintegritätsprüfung veröffentlicht. Nur Research-Unterstützung; keine persönliche Anlageberatung.
Mavefund ordnet die verfügbaren Fundamentaldaten, Bewertungskennzahlen und Risikofaktoren von Clorox Co für einen nachvollziehbaren Research-Prozess ein.
Score
Veröffentlichte Ergebnisse
Was das Unternehmen berichtet hat – mit kompakter Quellenangabe.
Quarterly result summary
EPS was $1.66 (reported).
Was sich verändert hat
- EPS reported to $1.66.
- Net income -50% YoY to $167M.
- Net sales decreased 2% to $1.95 billion. The GOJO acquisition added about 10 points. Organic sales 1 decreased 13%, primarily due to lapping the incremental shipments related to the ERP transition, which is about 13.5 points.
Guidance / outlook
we expect the operating environment to remain challenging, with continued cost volatility and a value-seeking consumer.
Source: SEC EDGAR company-filed earnings materials. Dates and source identifiers are retained for verification; review the original filing before relying on extracted report details.
Weitere aktuelle Ergebnisunterlagen
Geprüfte Signal-Evidenz
Aktuelle Nachrichten
Unternehmensrelevante Artikel aus Quellen, die die Relevanz- und Zuverlässigkeitsprüfung des Mave Signals bestehen.
Two Consumer Staples, Two Dividend Strategies: Church & Dwight (CHD) and The Clorox Company (CLX)
Headline from Yahoo Finance: Two Consumer Staples, Two Dividend Strategies: Church & Dwight (CHD) and The Clorox Company (CLX).
Clorox Co. stock underperforms Friday when compared to competitors
Headline from MarketWatch: Clorox Co. stock underperforms Friday when compared to competitors.
The Clorox Company (CLX) latest stock news and headlines
Headline from Yahoo Finance Singapore: The Clorox Company (CLX) latest stock news and headlines.
Clorox Co. stock underperforms Tuesday when compared to competitors
Headline from MarketWatch: Clorox Co. stock underperforms Tuesday when compared to competitors.
Should Passive Income Investors Buy Clorox Stock?
Headline from The Motley Fool: Should Passive Income Investors Buy Clorox Stock?
Clorox (CLX) Could Be 56% Below Fair Value As Valuation Views Split
Headline from Yahoo Finance: Clorox (CLX) Could Be 56% Below Fair Value As Valuation Views Split.
Gewinn je Aktie
Eigenkapitalrendite
Eigenkapitalrendite
Unternehmen —
Sektormedian —
Eigenkapitalrendite
Unternehmen —
Sektormedian —
Eigenkapitalrendite
Unternehmen —
Sektormedian —
Eigenkapitalrendite
Unternehmen —
Sektormedian —
Kennzahlen-Chart vorübergehend nicht verfügbar.
Nettomarge
Nettomarge
Unternehmen —
Sektormedian —
Nettomarge
Unternehmen —
Sektormedian —
Nettomarge
Unternehmen —
Sektormedian —
Nettomarge
Unternehmen —
Sektormedian —
Kennzahlen-Chart vorübergehend nicht verfügbar.
Verschuldung
Verschuldungsgrad
Unternehmen —
Sektormedian —
Verschuldungsgrad
Unternehmen —
Sektormedian —
Verschuldungsgrad
Unternehmen —
Sektormedian —
Verschuldungsgrad
Unternehmen —
Sektormedian —
Kennzahlen-Chart vorübergehend nicht verfügbar.
Finanzberichte
Vom Unternehmen veröffentlichte Berichtsdaten, strukturiert und mit der Originalquelle verknüpft.
Quellendetails werden mit den Berichtsdaten geladen. Die Werte sind standardisierte Unternehmensangaben zur Research-Unterstützung, keine persönliche Anlageberatung.